At Leeuwenhoek Laboratories, we believe that true precision health starts from the gut. By decoding the biochemical signals produced by gut microbiota, we aim to help individuals understand their physiological state, potential disease risks, and personalized intervention strategies—well before symptoms appear. Unlike traditional health checkups that provide only static snapshots, our approach focuses on real-time molecular changes, offering a new level of insight into your body’s dynamic balance. This enables earlier detection, personalized prevention, and more informed health decisions. Our precision health platform is built on high-resolution mass spectrometry, enabling rapid, high-throughput, and sensitive analysis of microbial metabolites. Through the development of gut microbiota–associated metabolomics, we offer targeted small-molecule profiling to assess early signs of disease—making us one of the few teams in Taiwan to provide such next-generation diagnostic tools.

We further expand our capabilities through four specialized laboratories. The Metabolomics and Precision Health Laboratory develops disease risk prediction platforms based on microbial metabolite signatures. The Next-Generation Probiotics Laboratory focuses on isolating promising local strains with health-promoting potential. The Bacterial Therapy Laboratory integrates in vitro and germ-free mouse models to validate the efficacy of novel strains beyond typical supplements. Lastly, the Research and Product Development Laboratory translates these discoveries into functional health solutions by combining beneficial strains with patented ingredients. By integrating scientific expertise, advanced analytics, and clinical relevance, Leeuwenhoek is bridging the gap between microbiome science and personal well-being—delivering actionable insights, personalized recommendations, and preventive strategies that redefine modern healthcare.